Andrew Logan, MD
Ophthalmology · Tamarac, FLNPI 1558430157
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.
Across 202 payments — averaging $25.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- NEW World Medical,inc.$526
- Bausch & Lomb Americas Inc.$469
- Bausch & Lomb, A Division Of Bausch Health US, LLC$430
- Alcon$388
- Aerie Pharmaceuticals, Inc.$248
- plus $2K from 25 others
Across 137 payments — averaging $6110.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$827K
- Ocular Therapeutix, Inc.$6K
- Shire North American Group Inc$4K
- Takeda Pharmaceuticals U.S.A., Inc.$800
What the payments were for
- Food & beverage$5,08998%
- Education$701%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $1,090 |
| NEW World Medical,inc. | 10 | $526 |
| Bausch & Lomb Americas Inc. | 22 | $469 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $430 |
| Alcon | 15 | $388 |
| Aerie Pharmaceuticals, Inc. | 12 | $248 |
| Harrow Eye, LLC | 8 | $203 |
| Abbott | 2 | $197 |
| Novartis | 10 | $190 |
| Carl Zeiss Meditec, Inc. | 2 | $186 |
| Beaver-visitec International, Inc. | 1 | $169 |
| Optos, Inc. | 1 | $99 |
| Mallinckrodt Hospital Products Inc. | 4 | $98 |
| Sun Pharmaceutical Industries Inc. | 5 | $95 |
| Amgen(2 entities) | 4 | $80 |
| Kala Pharmaceuticals, Inc. | 3 | $70 |
| Oyster Point Pharma, Inc. | 3 | $68 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $68 |
| Eyevance Pharmaceuticals LLC | 3 | $67 |
| Sight Sciences, Inc. | 3 | $67 |
| Optovue, Inc. | 1 | $66 |
| Tarsus Pharmaceuticals, Inc. | 2 | $55 |
| Astellas Pharma US Inc | 2 | $47 |
| Shire North American Group Inc | 2 | $44 |
| Topcon Healthcare, Inc. | 1 | $33 |
| GSK | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Carl Zeiss Meditec USA, Inc. | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Biotissue Holdings Inc. | 1 | $16 |
| Thea Pharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kahook Dual Blade$372
- Ahmed Glaucoma Valve$372
- Streamline Surgical System$215
- Clearpath$158
- Streamline$158
- Via360$158
- PROCLAIM$130
- OPMI Lumera$122
How this compares
$5,179 in reported general payments places this provider in the 75th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 297 | $236,477 |
| LumiganBimatoprost | 191 | $102,789 |
| RocklatanNetarsudil Mesylat/Latanoprost | 183 | $96,846 |
| CombiganBrimonidine Tartrate/Timolol | 151 | $58,780 |
| XiidraLifitegrast | 44 | $43,057 |
| RhopressaNetarsudil Mesylate | 68 | $35,543 |
| VyzultaLatanoprostene Bunod | 87 | $31,451 |
| Alphagan PBrimonidine Tartrate | 52 | $24,377 |
| Travoprost | 83 | $15,710 |
| IlevroNepafenac | 34 | $15,516 |
| Latanoprost | 1,186 | $13,058 |
| Prednisolone Acetate | 309 | $11,736 |
| Travatan ZTravoprost | 15 | $7,556 |
| Brimonidine Tartrate | 269 | $6,597 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 21 | $6,441 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $1,090 | $422,424691 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $248 | $132,389251 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $469 | $74,509131 claims |
| NovartisIlevro, Travatan Z | $190 | $23,07249 claims |
| AlconSimbrinza | $388 | $6,44121 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $430 | $4,19212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,405 ophthalmology providers in Florida.
Other ophthalmology in Tamarac
- Cathleen McCabeBradenton$2M
- Daniel KiernanSarasota$1.7M
- David EichenbaumSt Petersburg$1.7M
- Mark MilnerPalm Beach Gardens$1.2M
- Neel DesaiLargo$1M
- Jorge FortunPalm Beach Gardens$798K
- Courtney BoveeTampa$796K
- Harold BrooksTallahassee$683K
- Robert WeinstockLargo$605K
- William TrattlerMiami$579K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.